Nonstimulant ADHD Treatment Option Approved for Adults

The FDA has approved Qelbree for the treatment of ADHD in adults 18 years of age and older.

Related Keywords

,Drug Administration ,Supernus Pharmaceuticals Inc ,Symptom Rating Scale Total ,Clinical Global Impression ,Illness Scale ,Boxed Warning ,